Related Experiment Video
Updated: Aug 6, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Adverse effects of antiretroviral therapy in HIV-1 infected children
1Department of Pediatric HIV Clinic, B. J. Wadia Hospital for Children, Parel, Mumbai, India. irashah@pediatriconcall.com
Insights
Adverse effects from antiretroviral therapy (ART) are common in children with HIV-1. Hepatotoxicity, elevated serum amylase, and zidovudine-induced anemia were the most frequent, often reversible with dose adjustments.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- HIV/AIDS Research
Background:
- Antiretroviral therapy (ART) is crucial for managing HIV-1 infection in children.
- Understanding the adverse effects of ART is essential for optimizing treatment and patient outcomes.
- Pediatric populations may experience unique adverse events or different frequencies compared to adults.
Purpose of the Study:
- To prospectively identify and characterize adverse effects associated with ART in HIV-1 infected children.
- To determine factors, including viral load, associated with the occurrence of these adverse effects.
- To evaluate the reversibility and management strategies for ART-related adverse events in pediatric patients.
Main Methods:
- Prospective study conducted in a pediatric and perinatal HIV clinic.
- Involved 43 HIV-1 positive children aged 5 months to 14 years initiating ART.
- Adverse effects were monitored, documented, and analyzed in relation to viral load and treatment duration.
Main Results:
- 30% of children experienced ART-related adverse effects.
- Hepatotoxicity (16%), elevated serum amylase (12%), and zidovudine (AZT)-induced anemia (12%) were most common.
- Hepatotoxicity occurred at higher viral loads (mean 118,608 copies/ml) than elevated serum amylase (mean 37,631 copies/ml).
- Most adverse effects, including hepatotoxicity and AZT-induced anemia, were reversible with dose modification or drug omission.
Conclusions:
- Adverse effects are a significant concern in children receiving ART for HIV-1.
- Hepatotoxicity and hematologic abnormalities are common and require careful monitoring.
- Early identification and management, including dose adjustments or drug substitution, can effectively mitigate most adverse events.
Abstract:
The aim of this prospective study was to determine the adverse effects of antiretroviral therapy in HIV-1 infected children and factors associated with adverse effects. The study was performed in a pediatric and perinatal HIV clinic in a tertiary general hospital. Forty-three HIV positive children from the age group of 5 months to 14 years were started on antiretroviral therapy ART. Thirteen patients (30%) had adverse effects related to the ART. Seven patients (16%) had hepatotoxicity, 5 patients (12%) had raised serum amylase without symptomatic pancreatitis, 5 patients (12%) had zidovudine AZT induced anemia, 4 patients (9%) had Nevirapine NVP induced rash, 1 patient (2%) had Didanosine ddI induced pain in abdomen, 1 patient (2%) had Stavudine d4T induced angioedema, and 1 patient (2%) had hepatic steatosis. Five patients (71%) with hepatotoxicity responded to dose adjustment of ART whereas in 2 patients (29%), the elevated liver enzymes resolved on its own. Two patients (40%) with AZT induced anemia required omission of AZT and remaining 3 patients (60%) responded to dosage adjustment. ddI induced abdominal pain, d4T induced angioedema and hepatic steatosis resolved on omitting the respective antiretroviral drug. NVP induced rash and raised serum amylase subsided without any intervention. Hepatotoxicity was seen at higher viral load (Mean = 118608 copies/ml) whereas elevated serum amylase was seen at lower viral load (mean = 37631 copies/ml), which was statistically significant (p < 0.0001). NVP induced rash was seen in early weeks of therapy, serum amylase abnormalities were seen at a mean interval of 0.9 years after starting therapy, hepatotoxicity was seen at a mean interval of 1.7 years and AZT induced anemia was seen at a mean interval of 2.0 years after starting therapy. Adverse effects with antiretroviral drugs in HIV-infected children are quite common. Hepatotoxicity is the commonest adverse effect noted followed by elevated serum amylase and zidovudine induced anemia. Hepatotoxicity is seen at higher viral load as compared to other adverse effects. Most of the adverse effects are reversible on dosage modification or omitting the offending drug.
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

